Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      CaseBioscience® Joins Team Awarded Up to $7.3 Million by ARPA-H to Advance Ambient Preservation of Cell Therapies

      • USA - English
      • USA - čeština
      • USA - Français
      • USA - Deutsch
      • USA - Polski
      • USA - Pусский
      • USA - español
      • USA - slovenčina
      CaseBioscience®Innovative Quality Biosolutions

      News provided by

      CaseBioscience

      Oct 01, 2026, 17:08 ET

      Share this article

      SHARE A PRE-MADE POST

      Share this article

      SHARE A PRE-MADE POST

      FORT COLLINS, Colo., Oct. 1, 2026 /PRNewswire/ -- CaseBioscience® today announced its participation in a multidisciplinary team led by Likarda that has been awarded up to $7.3 million by the Advanced Research Projects Agency for Health (ARPA-H) through its BioStabilization Systems (BoSS) program.

      The BoSS program aims to foster new technologies to produce, store, and ship cells at room temperature without the need for refrigeration. As the BoSS team states, the goal is to make the most advanced biological medicines as "easy to ship and store as aspirin."

      Continue Reading
      ARPA-H BioStabilization Systems (BoSS) program. Image courtesy of the Advanced Research Projects Agency for Health (ARPA-H).
      ARPA-H BioStabilization Systems (BoSS) program. Image courtesy of the Advanced Research Projects Agency for Health (ARPA-H).

      Led by Likarda, the Reversible Ambient Biostabilization (RAB) team is one of only three teams selected for the BoSS program. The team brings together expertise spanning preservation science, cell biology, cellular metabolism, bioengineering, immunology, stem cell biology, formulation, and manufacturing.

      Program at a Glance

      • Program: ARPA-H BioStabilization Systems (BoSS)
      • Project: Reversible Ambient Biostabilization (RAB)
      • Award: Up to $7.3 million
      • Team: CaseBioscience, Draper, CPSI Biotech, Fresenius Kabi, Likarda, MiNK Therapeutics, and the Spencer Lab at the University of Colorado Boulder
      • Objective: Develop new approaches for the ambient storage and transport of living cellular medicines, reducing dependence on cold-chain logistics
      • Initial Phase: 15 months, commencing September 24, 2026

      The team will work to reduce dependence on cold-chain logistics by integrating specialized physiological mechanisms, novel cell-protective strategies, and bioengineering approaches to develop new methods for the ambient storage and transport of cellular medicines.

      Learn more about CaseBioscience's participation in the ARPA-H BoSS program and discover the latest news and developments from CaseBioscience.

      Cell therapies have demonstrated the potential to transform the treatment of cancer and other serious diseases, but their broader accessibility remains constrained in part by the complexity and cost of cold-chain logistics. Many cell-based products require specialized preservation, storage, and transportation conditions to maintain viability and function. Technologies capable of stabilizing therapeutic cells at ambient temperatures could significantly simplify distribution, reduce logistical barriers, and help expand access to these advanced medicines.

      "The concept of preserving living cells in a dry state has been pursued for more than two decades, but significant scientific and engineering barriers have yielded limited success," said Dr. John Baust, a leader in the field of biopreservation and collaborator on the project with CPSI Biotech. "ARPA-H's BoSS program provides an unprecedented opportunity to tackle this from multiple scientific and engineering directions simultaneously. If successful, this work could represent a paradigm shift in how biologics are preserved, stored, and distributed."

      The program also builds on research with deep roots within the CaseBioscience scientific team. Dr. Lynda McGinnis, R&D Director at CaseBioscience, helped pioneer early research into desiccated storage of sperm more than two decades ago.

      "This is a great opportunity to revisit research that some of us started in Boston 25 years ago," said Dr. McGinnis. "It's time for a whole new paradigm of how we store and transport cells for clinical therapies and even reproductive medicine."

      CaseBioscience® will contribute its expertise in clinical media formulation, biopreservation, and cellular metabolism to the development and evaluation of novel approaches for long-term ambient stabilization of therapeutic cells.

      "We are excited to be part of a program with the scientific depth and resources to pursue ideas that could meaningfully advance the field," said Dr. Kevin Flynn, Chief Scientific Officer at CaseBioscience. "This is an opportunity to bring our capabilities to an exceptional collaboration, explore what has not yet been possible, and turn that potential into progress."

      "We are very proud that CaseBioscience has been selected by ARPA-H to be part of the BoSS program. This award is a strong validation of our science, our preservation technology, and the team behind it. Making living cell therapies as easy to store and ship as conventional medicines would fundamentally change who can access them, and we are honored to be working alongside such an exceptional group of partners towards that goal," said Ami Mezezi, Co-Founder and Managing Director of CaseBioscience.

      The first phase of the BoSS program is now underway, with the RAB team beginning its collaborative research and development efforts.

      About CaseBioscience®

      CaseBioscience is a life sciences company developing and manufacturing advanced media and preservation solutions for cell therapy, regenerative medicine, and assisted reproductive technology. Combining expertise in cell biology, cellular metabolism, formulation science, and biopreservation, CaseBioscience develops solutions designed to support cell health, consistency, and performance from research through clinical applications. The company operates under an ISO 13485:2016-certified quality system, with an FDA-registered manufacturing facility and research and development operations in Colorado. CaseBioscience also partners with biotechnology and pharmaceutical organizations to develop and manufacture specialized media and preservation solutions.

      For more information, visit CaseBioscience.com.

      Modal title

      Also from this source

      CaseBioscience® schließt sich einem Team an, das von ARPA-H bis zu 7,3 Millionen US-Dollar für die Weiterentwicklung der Lagerung von Zelltherapien bei Raumtemperatur erhält

      CaseBioscience® schließt sich einem Team an, das von ARPA-H bis zu 7,3 Millionen US-Dollar für die Weiterentwicklung der Lagerung von Zelltherapien bei Raumtemperatur erhält

      CaseBioscience® gab heute seine Beteiligung an einem multidisziplinären Team unter der Leitung von Likarda bekannt, dem von der Advanced Research...

      CaseBioscience® присоединяется к команде, получившей до $7,3 млн от ARPA-H на развитие технологий консервации и хранения клеточных лекарственных препаратов при комнатной температуре

      CaseBioscience® присоединяется к команде, получившей до $7,3 млн от ARPA-H на развитие технологий консервации и хранения клеточных лекарственных препаратов при комнатной температуре

      CaseBioscience® сегодня объявила об участии в междисциплинарной команде под руководством Likarda, которая получила до $7,3 млн от Advanced Research...

      More Releases From This Source

      Explore

      Biotechnology

      Biotechnology

      STEM (Science, Tech, Engineering, Math)

      STEM (Science, Tech, Engineering, Math)

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Health Care & Hospitals

      Health Care & Hospitals

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.